Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Straus

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Cancer|December 1, 1976
Combination chemotherapy in advanced lung cancer with increased survivalM J Straus
Cancer Treatment Reports|May 1, 1979
Cytokinetic chemotherapy design for the treatment of advanced lung cancerM J Straus
The American Review of Respiratory Disease|November 1, 1979
New developments in the treatment of advanced lung cancerM J Straus
The Western Journal of Medicine|June 1, 1992
Twelve more wordsM J Straus
The Western Journal of Medicine|June 1, 1992
Twelve wordsM J Straus
Seminars in Oncology|September 1, 1974
The growth characteristics of lung cancer and its application to treatment designM J Straus
Seminars in Oncology|September 1, 1974
Lung cancer:1974M J Straus
Cancer Chemotherapy Reports|February 1, 1972
Effect of day of dosage omission on survival time in the regularly scheduled methotrexate (NSC-740) treatment of leukemia L1210M J Straus, A Goldin
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1974
Effects of priming dose schedules in cytoxan treatment of mouse leukemia L1210M J Straus, A Goldin
Cancer Chemotherapy Reports|February 1, 1972
Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210M J Straus, A Goldin
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Cancer|December 1, 1976
Combination chemotherapy in advanced lung cancer with increased survivalM J Straus
Cancer Treatment Reports|May 1, 1979
Cytokinetic chemotherapy design for the treatment of advanced lung cancerM J Straus
The American Review of Respiratory Disease|November 1, 1979
New developments in the treatment of advanced lung cancerM J Straus
The Western Journal of Medicine|June 1, 1992
Twelve more wordsM J Straus
The Western Journal of Medicine|June 1, 1992
Twelve wordsM J Straus
Seminars in Oncology|September 1, 1974
The growth characteristics of lung cancer and its application to treatment designM J Straus
Seminars in Oncology|September 1, 1974
Lung cancer:1974M J Straus
Cancer Chemotherapy Reports|February 1, 1972
Effect of day of dosage omission on survival time in the regularly scheduled methotrexate (NSC-740) treatment of leukemia L1210M J Straus, A Goldin
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1974
Effects of priming dose schedules in cytoxan treatment of mouse leukemia L1210M J Straus, A Goldin
Cancer Chemotherapy Reports|February 1, 1972
Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210M J Straus, A Goldin
Pageof 4